Your browser doesn't support javascript.
loading
Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model.
Takamiya, Soichiro; Kawabori, Masahito; Kitahashi, Tsukasa; Nakamura, Kentaro; Mizuno, Yuki; Yasui, Hironobu; Kuge, Yuji; Tanimori, Aki; Takamatsu, Yasuyuki; Yuyama, Kohei; Shichinohe, Hideo; Fujimura, Miki.
Afiliación
  • Takamiya S; Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Kawabori M; Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Kitahashi T; Bioscience & Engineering Laboratory, FUJIFILM Corporation, Kanagawa, Japan.
  • Nakamura K; Bioscience & Engineering Laboratory, FUJIFILM Corporation, Kanagawa, Japan.
  • Mizuno Y; Central Institute of Isotope Science, Hokkaido University, Sapporo, Japan.
  • Yasui H; Central Institute of Isotope Science, Hokkaido University, Sapporo, Japan.
  • Kuge Y; Department of Applied Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
  • Tanimori A; Central Institute of Isotope Science, Hokkaido University, Sapporo, Japan.
  • Takamatsu Y; Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yuyama K; Department of Rehabilitation Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.
  • Shichinohe H; Lipid Biofunction Section, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan.
  • Fujimura M; Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan.
Stem Cells Int ; 2022: 8521922, 2022.
Article en En | MEDLINE | ID: mdl-35966129
ABSTRACT

Background:

Due to the lack of effective therapies, stem cell transplantation is an anticipated treatment for chronic intracerebral hemorrhage (ICH), and higher cell survival and engraftment are considered to be the key for recovery. Mesenchymal stromal cells (MSCs) compounded with recombinant human collagen type I scaffolds (CellSaics) have a higher potential for cell survival and engraftment compared with solo-MSCs, and we investigated the validity of intracerebral transplantation of CellSaic in a chronic ICH model.

Methods:

Rat CellSaics (rCellSaics) were produced by rat bone marrow-derived MSC (rBMSCs). The secretion potential of neurotrophic factors and the cell proliferation rate were compared under oxygen-glucose deprivation (OGD) conditions. rCellSaics, rBMSCs, or saline were transplanted into the hollow cavity of a rat chronic ICH model. Functional and histological analyses were evaluated, and single-photon emission computed tomography for benzodiazepine receptors was performed to monitor sequential changes in neuronal integrity. Furthermore, human CellSaics (hCellSaics) were transplanted into a chronic ICH model in immunodeficient rats. Antibodies neutralizing brain-derived neurotrophic factor (BDNF) were used to elucidate its mode of action.

Results:

rCellSaics demonstrated a higher secretion potential of trophic factors and showed better cell proliferation in the OGD condition. Animals receiving rCellSaics displayed better neurological recovery, higher intracerebral BDNF, and better cell engraftment; they also showed a tendency for less brain atrophy and higher benzodiazepine receptor preservation. hCellSaics also promoted significant functional recovery, which was reversed by BDNF neutralization.

Conclusion:

Intracerebral transplantation of CellSaics enabled neurological recovery in a chronic ICH model and may be a good option for clinical application.

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Stem Cells Int Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Stem Cells Int Año: 2022 Tipo del documento: Article País de afiliación: Japón